Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Carl Zeiss Meditec’s Taylor takes helm at VC-backed eye firm

This article was originally published in Clinica

Executive Summary

Jim Taylor has joined Oraya Therapeutics, a clinical-stage company developing a radiosurgical system for treating eye disorders, as president and CEO. Mr Taylor has over 25 years’ experience in the medtech industry, of which a significant part was in the ophthalmic sector. Before joining Newark, California-based Oraya, he led ophthalmic diagnostic and treatment systems manufacturer Carl Zeiss Meditec for seven years. Prior to that, he was president of Coherent Medical Group's ophthalmic and surgical lasers business. The appointment of Mr Taylor follows shortly after Oraya raised $42m in series C financing to expand international trials of its treatment for wet age-related macular degeneration.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043979

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel